TFEB- and TFE3-dependent autophagy activation supports cancer proliferation in the absence of centrosomes

Chien-Han Kao,Ting-Yu Su,Wei-Syun Huang,Xin-Ying Lu,Wann-Neng Jane,Chien-Yung Huang,Hung-Hsiang Huang,Won-Jing Wang
DOI: https://doi.org/10.1080/15548627.2022.2051880
IF: 13.391
2022-03-22
Autophagy
Abstract:Centrosome amplification is a phenomenon frequently observed in human cancers, so centrosome depletion has been proposed as a therapeutic strategy. However, despite being afflicted with a lack of centrosomes, many cancer cells can still proliferate, implying there are impediments to adopting centrosome depletion as a treatment strategy. Here, we show that TFEB- and TFE3-dependent autophagy activation contributes to acentrosomal cancer proliferation. Our biochemical analyses uncover that both TFEB and TFE3 are novel PLK4 (polo like kinase 4) substrates. Centrosome depletion inactivates PLK4, resulting in TFEB and TFE3 dephosphorylation and subsequent promotion of TFEB and TFE3 nuclear translocation and transcriptional activation of autophagy- and lysosome-related genes. A combination of centrosome depletion and inhibition of the TFEB-TFE3 autophagy-lysosome pathway induced strongly anti-proliferative effects in cancer cells. Thus, our findings point to a new strategy for combating cancer.
cell biology
What problem does this paper attempt to address?